- Report
- October 2021
- 306 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- April 2021
- 377 Pages
Global
From €3489EUR$3,995USD£3,031GBP
- Report
- March 2021
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- July 2023
- 280 Pages
Global
From €2140EUR$2,450USD£1,859GBP
- Report
- November 2022
- 340 Pages
Global
From €2096EUR$2,400USD£1,821GBP
- Report
- January 2022
- 194 Pages
Global
From €1921EUR$2,200USD£1,669GBP
- Report
- October 2021
- 190 Pages
Global
From €1747EUR$2,000USD£1,517GBP
From €1747EUR$2,000USD£1,517GBP
- Report
- March 2021
- 214 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- August 2023
- 116 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- June 2025
- 200 Pages
Australia
From €2175EUR$2,490USD£1,889GBP
- Report
- July 2024
- 168 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2175EUR$2,490USD£1,889GBP
- Report
- July 2025
- 200 Pages
Mexico
From €2175EUR$2,490USD£1,889GBP
- Report
- November 2022
- 125 Pages
Global
From €2175EUR$2,490USD£1,889GBP
- Report
- February 2024
- 209 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- April 2023
- 275 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- January 2023
- 343 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- July 2022
- 276 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- July 2022
- 416 Pages
Global
From €4367EUR$5,000USD£3,793GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more